Tamsulosin Hydrochloride
Product Images NDC 66336-902

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 66336-902). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 66336-0902-xx (Ndc 66336 0902 Xx Caraco)

Label for Tamsulosin Hydrochloride 0.4 mg capsules by Dispensing Solutions, Inc. The label includes dosage strength, capsule form, and a National Drug Code (NDC 66336-0902). It also contains manufacturer and distributor information, warnings about storage temperature and child safety, and instructions to take capsules orally 30 minutes after meals. The label states "Rx Only" and includes batch and expiration data fields marked as samples.*

FDA Label Image

Figure-1 (Tamsulosin Fig1)

A line graph showing plasma concentration (ng/mL) of Tamsulosin Hydrochloride over time (hours) comparing fed and fasted states. The plasma concentration peaks higher and earlier in the fasted state than in the fed state, with levels declining over a 36-hour period.*

FDA Label Image

Figure-2a (Tamsulosin Fig2a)

A line graph showing mean change over duration of treatment in weeks for Tamsulosin Hydrochloride doses 0.4 mg and 0.8 mg compared to placebo. The x-axis represents treatment weeks, while the y-axis shows mean change values. Data points indicate sample sizes at each time point.*

FDA Label Image

Figure-2b (Tamsulosin Fig2b)

A line graph depicting the mean change over the duration of treatment in weeks for three groups: Tamsulosin Hydrochloride 0.8 mg, 0.4 mg, and placebo. The x-axis represents treatment duration (0 to 13 weeks) and the y-axis shows mean change, with data points connected for each group. Sample sizes at each time point are noted below the axis, highlighting mean change trends across treatment duration.*

FDA Label Image

Tamsulosin-fig3a (Tamsulosin Fig3a)

A line graph showing mean change in flow rate (mL/sec) over duration of treatment in weeks for three groups: 0.8 mg, 0.4 mg Tamsulosin Hydrochloride treatments, and placebo. The graph tracks data from baseline through 13 weeks and LOCF with sample sizes noted at time points.*

FDA Label Image

Tamsulosin-fig3b (Tamsulosin Fig3b)

Line graph depicting mean change in mL/sec over treatment duration in weeks, comparing three groups: 0.8 mg dosage, 0.4 mg dosage, and placebo. The graph shows the progression in mean change for each group across multiple time points, concluding with a last observation carried forward (LOCF) value. Sample sizes for each time point are shown below the x-axis.*

FDA Label Image

Chemical-structure (Tamsulosin Str)

Chemical structure of Tamsulosin Hydrochloride showing its molecular arrangement, including aromatic rings and functional groups relevant to the active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.